Smith & Nephew Snats ( (SNN) ) just unveiled an update.
On March 26, 2025, Smith & Nephew plc announced the granting of awards under its Deferred Share Bonus Plan and Global Share Plan 2020. These awards, based on the company’s 2024 performance, involve deferred shares for executive directors and PDMRs, with vesting periods extending to 2028. This initiative aligns with the company’s strategy to incentivize management and align their interests with shareholders, potentially impacting the company’s market positioning and stakeholder confidence.
More about Smith & Nephew Snats
Smith & Nephew plc is a global medical technology company that specializes in the production of advanced medical devices, including orthopaedic reconstruction, advanced wound management, and sports medicine products. The company is focused on improving patient outcomes and operates within the healthcare industry.
YTD Price Performance: 16.43%
Average Trading Volume: 784,846
Technical Sentiment Signal: Sell
Current Market Cap: $12.4B
Find detailed analytics on SNN stock on TipRanks’ Stock Analysis page.